Evaluation of Circulating Tumor Cells (CTC) Relevance in Breast Cancer Follow-up Using the ScreenCell Device

Clinical trial NCT06807502 · RECRUITING

Trial details

NCT number: NCT06807502
Sponsor: ScreenCell
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Breast Cancer, Metastatic Breast Cancer Invasive Breast Cancer Early Stage Breast Cancer (Stage 1-3)

Start date: 2025-02-24
Primary completion: 2026-09-30
Enrollment: 93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.